Thyrocare shares jumped 13% after Q1 net profit rose 60% YoY to Rs 38 crore; revenue up 23% to Rs 193 crore.
Normalised EBITDA grew 42% YoY to Rs 63 crore; EBITDA margin improved to 33% from 29%.
Pathology franchise revenue rose 20%, partnership revenue up 36%; test volume increased 15% YoY to 46.9 million.
New labs opened in Bhagalpur, Kashmir, and Roorkee; gross margin stood at 71%.
Comments
Post a Comment